A energy research peptide. Live vendor vial prices, sorted lowest first.
For research use only. Not for human consumption. No health, dosing, or usage claims are made.
MOTS-c is a mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region and studied as a regulator of cellular metabolism. It is not an approved drug and is sold only as a research chemical.
PubChem CID 146675088 is titled MOTS-c but lists no CAS synonym, so the on-file CAS 1627580-64-6 could not be confirmed against PubChem; treat that CAS as unverified.
Regulatory status: As of 2026, MOTS-c is not FDA-approved; it was nominated for the compounding bulk-substances list and placed in Category 2, but that nomination was later withdrawn by the nominator, and MOTS-c is scheduled for further FDA advisory-committee discussion in July 2026 (FDA Category 2 page, current as of 04/22/2026).
Typical vendor vial prices, Jul 2026. Exact prices load with verified listings.
| Vendor | Vial price | |
|---|---|---|
Simple Peptide | $0.05Best | View vendor › |
Precision Research Peptides | $0.13 | View vendor › |
Prime Lab Peptides | $0.16 | View vendor › |
Koi Peptides | $0.18 | View vendor › |
Protide Health | $0.20 | View vendor › |
BioInfinity Lab | $0.22 | View vendor › |
Kaia Peptides | $0.33 | View vendor › |
BioLongevity Labs | $0.50 | View vendor › |
Mile High Compounds | $1 | View vendor › |
PSPeptides | $3.60 | View vendor › |
Skye Peptides | $8.80 | View vendor › |
Studied in cell and animal models of metabolism and aging; these are areas of laboratory study and do not indicate a proven effect in people.
Planning a reconstitution? Use the calculator — it is math for handling a vial, not dosing.
Sources & further reading: PubChem CID 146675088 (NCBI) · MOTS-c mitochondrial-derived peptide review (NCBI PMC) · FDA — Bulk Drug Substances That May Present Significant Safety Risks (Category 2)
How we source this ›